Do you want to read an article? Please log in or register.
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
Lung Cancer
Related content
Lung Cancer
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203)
Clin Lung Cancer
Lin JX, Zhou Q, Yan HH, Liu AW, Wu GW, Chu Q, Du YY, Cui JW, Cheng Y, Yang Y, Xu HP, Tu HY, Wu YL, Liu SM
doi: 10.1016/j.cllc.2025.05.014
Lung Cancer
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK-positive Non-Small-Cell Lung Cancer According to ALK Fusion and Mutation Status
Clin Lung Cancer
Bazhenova L, Hodgson JG, Camidge DR, Langer CJ, Huber RM, Kim DW, Reckamp KL, Ahn MJ, Tan DSW, Patel JD, Vincent S, Li C, Humphries MJ, Zhang P, Rivera VM, Gettinger S
doi: 10.1016/j.cllc.2025.05.016
Sleep Apnea
Evaluation and management of obstructive sleep apnea in adults hospitalized for medical care: an American Academy of Sleep Medicine clinical practice guideline
J Clin Sleep Med
Mehra R, Auckley DH, Johnson KG, Billings ME, Carandang G, Khayat RN, Pena-Orbea C, Sahni AS, Sharma S, Patil SP
doi: 10.5664/jcsm.11864
Lung Cancer
Management of Patients with Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline
Chest
Howington J, Souter LH, Arenberg D, Blasberg J, Detterbeck F, Farjah F, Lanuti M, Leighl N, Videtic GM, Murthy S
doi: 10.1016/j.chest.2025.06.023
Lung Cancer
Clinical Outcomes of Patients With Advanced ALK-Rearranged Lung Squamous Cell Carcinoma Treated With ALK Tyrosine Kinase Inhibitors
Clin Lung Cancer
Sun Y, Yang D, Huang Z, Yan H, Zeng L, Xu Q, Song L, Zhou C, Peng L, Xiao J, Lin S, Zhou Z, Xiang S, Ruan Z, Yang N, Zhang Y
doi: 10.1016/j.cllc.2025.07.011
RECOMMENDED
Pulmonary Hypertension
Advanced Management of Patients Undergoing Transcatheter Treatment for Pulmonary Embolism: Evidence-Based Strategies for Optimized Patient Care
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Costa F, Jurado-Román A, Carciotto G, Becerra-Munoz V, Márquez DT, Götzinger F, Cerrato E, Misra S, Spissu M, Pavani M, Mennuni M, Chinchilla FC, Dominguez-Franco A, Muñoz-Garcia A, Navarrete RS, Varbella F, Salinas-Sanguino P, Secemsky EA, Mahfoud F, Micari A, Alonso-Briales JH, Navarro MJ
doi: 10.3390/jcm13247780
Further Publications
The one-minute sit-to-stand test: A practical tool for assessing functional exercise capacity in patients with COPD in routine clinical practice
Chron Respir Dis
Mellaerts P, Demeyer H, Blondeel A, Vanhoutte T, Breuls S, Wuyts M, Coosemans I, Claes L, Vandenbergh N, Beckers K, Bossche LV, Stylemans D, Janssens W, Everaerts S, Troosters T
doi: 10.1177/14799731241291530
RECOMMENDED
Lung Cancer
Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Saw SPL, Zhong WZ, Fu R, Li MSC, Goto Y, Fox SB, Yatabe Y, Ong BH, Ng CSH, Lee DDW, Cam Phuong P, Park IK, Yang JCH, Tsuboi M, Tho LM, John T, Hsu HH, Tan DSW, Mok TSK, Reungwetwattana T, Singh N
doi: 10.1016/j.lungcan.2024.108076
Lung Cancer
Survival and recurrence rates following SBRT or surgery in medically operable Stage I NSCLC
Lung Cancer
Snider M, Salama JK, Boyer M
doi: 10.1016/j.lungcan.2024.107962